Experts clarify differences between glioblastoma and diffuse midline glioma under 2021 WHO classification
In the opening episode of their series, Dr. Shonka and Dr. Chong introduce a discussion about two distinct diseases that both carry the name glioma.
They explain that glioblastoma and diffuse midline glioma differ fundamentally in their underlying biology, the patient populations they affect, and the therapeutic approaches used to treat them.
The conversation references the 2021 World Health Organization classification, which formally separates these entities to improve diagnosis and guide treatment decisions.
This writeup was produced by pharmadog from original reporting by onclive. The original article may no longer be reachable at its published URL.
Original headline: “Two Diseases That Share a Name — Defining Glioblastoma and Diffuse Midline Glioma Under the 2021 WHO Classification”
read at onclive ↗
comments(0)
5-min edit window · permanent after that